JWCTF
Price:
$0.162
Market Cap:
$586.80M
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company's pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for th...[Read more]
Industry
Biotechnology
IPO Date
2021-07-15
Stock Exchange
PNK
Ticker
JWCTF
According to JW (Cayman) Therapeutics Co. Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 251.83M. This represents a change of 65.29% compared to the average of 152.35M of the last 4 quarters.
The mean historical Enterprise Value of JW (Cayman) Therapeutics Co. Ltd over the last ten years is 1.74B. The current 251.83M Enterprise Value has changed 1.35% with respect to the historical average. Over the past ten years (40 quarters), JWCTF's Enterprise Value was at its highest in in the June 2021 quarter at 5.70B. The Enterprise Value was at its lowest in in the January 2018 quarter at 0.
Average
1.74B
Median
470.98M
Minimum
155.61M
Maximum
7.19B
Discovering the peaks and valleys of JW (Cayman) Therapeutics Co. Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 550.14%
Maximum Annual Enterprise Value = 7.19B
Minimum Annual Increase = -84.69%
Minimum Annual Enterprise Value = 155.61M
Year | Enterprise Value | Change |
---|---|---|
2024 | 162.29M | 4.29% |
2023 | 155.61M | -66.96% |
2022 | 470.98M | -82.39% |
2021 | 2.68B | 550.14% |
2020 | 411.46M | -62.61% |
2019 | 1.10B | -84.69% |
The current Enterprise Value of JW (Cayman) Therapeutics Co. Ltd (JWCTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
262.96M
5-year avg
775.08M
10-year avg
1.74B
JW (Cayman) Therapeutics Co. Ltd’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like JW (Cayman) Therapeutics Co. Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like JW (Cayman) Therapeutics Co. Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is JW (Cayman) Therapeutics Co. Ltd's Enterprise Value?
What is the highest Enterprise Value for JW (Cayman) Therapeutics Co. Ltd (JWCTF)?
What is the 3-year average Enterprise Value for JW (Cayman) Therapeutics Co. Ltd (JWCTF)?
What is the 5-year average Enterprise Value for JW (Cayman) Therapeutics Co. Ltd (JWCTF)?
How does the current Enterprise Value for JW (Cayman) Therapeutics Co. Ltd (JWCTF) compare to its historical average?